RxDoctor Payments Data

Lauren Walter, DO

Internal Medicine · Solon, OHNPI 1144587148

Payments from drug & device makers

$1,362in general payments, 2019–2025

Across 73 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$284
  • Gilead$121
  • GSK$104
  • Abbott$96
  • AstraZeneca$93
  • Lilly USA, LLC$84
  • plus $580 from 14 others

What the payments were for

  • Food & beverage$1,362100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,362 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$32,484
Medicare patients
78
Services billed
364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide58$71,834
TrulicityDulaglutide55$63,219
MounjaroTirzepatide38$50,145
FarxigaDapagliflozin Propanediol37$41,468
JardianceEmpagliflozin35$39,085
Trelegy ElliptaFluticasone/Umeclidin/Vilanter28$30,642
EliquisApixaban27$28,735
XareltoRivaroxaban25$22,739
RybelsusSemaglutide13$20,271
Repatha SureclickEvolocumab17$9,642
Breo ElliptaFluticasone/Vilanterol18$7,645
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$6,353
Praluent PenAlirocumab12$5,977
Albuterol Sulfate HfaAlbuterol Sulfate80$3,982
Atorvastatin Calcium310$2,851

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$84$113,36393 claims
Novo NordiskOzempic, Rybelsus$42$92,10571 claims
AstraZenecaFarxiga$93$41,46837 claims
Boehringer IngelheimJardiance$27$39,08535 claims
GSKTrelegy Ellipta, Breo Ellipta$104$38,28746 claims
PfizerEliquis$36$28,73527 claims
Johnson & JohnsonXarelto$77$22,73925 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Solon

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →